Originally introduced in 2017, semaglutide was utilized for managing blood sugar in Type 2 diabetes. Individuals who use semaglutide for blood sugar management often experienced an added benefit of weight loss.

Administered once weekly, semaglutide is an injectable glucagon-like peptide-1 (GLP-1) agonist. GLP-1 is an incretin hormone influencing appetite and digestion. After meals, your body releases incretins, which lower blood sugar, trigger insulin, and slow stomach emptying. This leads to a sense of fullness, aiding weight loss. Medications that are GLP-1 agonists, such as semaglutide, mirror these effects.

Compounded semaglutide is highly recommended for weight loss purposes. It is recommended to incorporate compounded semaglutide in conjunction with lifestyle adjustments, encompassing a balanced diet and regular exercise.